Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 9(4): e95080, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24762746

RESUMO

BACKGROUND AND AIMS: Azathioprine (AZA) is widely used for the treatment of inflammatory bowel disease (IBD) patients. AZA is catabolized by thiopurine S-methyltransferase (TPMT), which exhibits genetic polymorphisms. It has also been reported that 5-aminosalicylic acid (5-ASA) inhibits TPMT activity, and that increased 6-thioguanine nucleotide (6-TGN, a metabolite of AZA) blood concentrations result in an increased number of ADRs. In this study, single nucleotide polymorphisms (SNPs) related to differential gene expression affecting AZA drug metabolism in combination therapy with 5-ASA were examined. METHODS: To identify genetic biomarkers for the prediction of 6-TGN blood concentration, ExpressGenotyping analysis was used. ExpressGenotyping analysis is able to detect critical pharmacogenetic SNPs by analyzing drug-induced expression allelic imbalance (EAI) of premature RNA in HapMap lymphocytes. We collected blood samples on 38 patients with inflammatory bowel disease treated with AZA and corroboration of the obtained SNPs was attempted in clinical samples. RESULTS: A large number of SNPs with AZA/5-ASA-induced EAI within the investigated HapMap lymphocytes was identified by ExpressGenotyping analysis. The respective SNPs were analyzed in IBD patients' blood samples. Among these SNPs, several that have not yet been described to be induced by AZA/5-ASA were found. SNPs within SLC38A9 showed a particular correlation with patients' 6-TGN blood concentrations. CONCLUSIONS: Based on these results, ExpressGenotyping analysis and genotyping of patients appears to be a useful way to identify inter-individual differences in drug responses and ADRs to AZA/5-ASA. This study provides helpful information on genetic biomarkers for optimized AZA/5-ASA treatment of IBD patients.


Assuntos
Sistemas de Transporte de Aminoácidos/genética , Azatioprina/farmacocinética , Imunossupressores/farmacocinética , Doenças Inflamatórias Intestinais/sangue , Mesalamina/uso terapêutico , Adulto , Anti-Inflamatórios não Esteroides/uso terapêutico , Azatioprina/uso terapêutico , Células Cultivadas , Quimioterapia Combinada , Feminino , Estudos de Associação Genética , Marcadores Genéticos , Humanos , Imunossupressores/uso terapêutico , Doenças Inflamatórias Intestinais/tratamento farmacológico , Linfócitos/efeitos dos fármacos , Linfócitos/metabolismo , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único
2.
Int J Cancer ; 115(3): 377-82, 2005 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-15700314

RESUMO

Hybrid liposomes can be prepared by simply ultrasonicating a mixture of vesicular and micellar molecules in a buffer solution. The physical properties of these liposomes, such as size, membrane fluidity, phase transition temperature and hydrophobicity can be controlled by changing the composition. Hybrid liposomes composed of dimyristoylphosphatidylcholine and polyoxyethylene (10) dodecyl ether were found to inhibit the growth of human promyelocytic leukemia (HL-60) cells without using any drugs. Induction of apoptosis by hybrid liposomes in HL-60 cells was verified on the basis of fluorescence microscopy and flow cytometry analysis, after fusion and accumulation of hybrid liposomes, which was revealed on the basis of microphysiometer. We elucidated the pathways of apoptosis induced by the hybrid liposomes. That is, hybrid liposomes fused and accumulated in tumor cell membranes, and the apoptosis signal first passed through mitochondria, caspase-9 and caspase-3, second through Fas, caspase-8, caspase-3 and then reached the nucleus. Hybrid liposomes themselves can induce apoptosis in human tumor cells along with high inhibitory effects on the growth of tumor cells.


Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Membrana Celular/metabolismo , Dimiristoilfosfatidilcolina/farmacologia , Lipossomos/farmacologia , Polietilenoglicóis/farmacologia , Antineoplásicos/metabolismo , Caspase 3 , Caspase 8 , Caspase 9 , Caspases/metabolismo , Núcleo Celular/metabolismo , Proliferação de Células/efeitos dos fármacos , Citocromos c/metabolismo , Proteínas Adaptadoras de Sinalização de Receptores de Domínio de Morte , Dimiristoilfosfatidilcolina/metabolismo , Células HL-60/efeitos dos fármacos , Células HL-60/metabolismo , Células HL-60/patologia , Humanos , Indicadores e Reagentes/metabolismo , Indicadores e Reagentes/farmacologia , Lipossomos/metabolismo , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Polidocanol , Polietilenoglicóis/metabolismo , Receptores do Fator de Necrose Tumoral/metabolismo
3.
Int J Pharm ; 292(1-2): 231-9, 2005 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-15725570

RESUMO

Hybrid liposomes can be prepared by simply ultrasonicating a mixture of vesicular and micellar molecules in aqueous solution. A clear solution of hybrid liposomes composed of 90 mol% dimyristoylphosphatidylcholine (DMPC) and 10 mol% polyoxyethylene(23)dodecyl ether (C12(EO)23) having a hydrodynamic diameter of 100-120 nm was obtained. Highly inhibitory effects of hybrid liposomes of 90 mol% DMPC/10 mol% C12(EO)23 on the growth of human lung carcinoma (RERF-LC-OK and A549) cells without any drugs were obtained. Induction of apoptosis by hybrid liposomes in RERF-LC-OK and A549 cells was verified on the basis of fluorescence microscopy, agarose gel electrophoresis of DNA and flow cytometry. We elucidated the pathway of apoptosis induced by hybrid liposomes as follows: (a) accumulation of hybrid liposomes in tumor cell membrane was revealed using microphysiometer. (b) Reduction of mitochodrial membrane potential and activation of caspase-9, -3 and -8 were obtained, indicating that apoptotic signal by hybrid liposomes should pass through mitochondria and these caspases. It is worthy to note that such a novel mechanism of apoptosis induced by hybrid liposomes without any drugs was performed for the first time in human lung carcinoma cells.


Assuntos
Linhagem Celular Tumoral , Fragmentação do DNA/efeitos dos fármacos , Lipossomos/análise , Polietilenoglicóis/análise , Polietilenoglicóis/farmacocinética , Técnicas Biossensoriais/métodos , Caspases/efeitos dos fármacos , Caspases/metabolismo , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Proliferação de Células/efeitos dos fármacos , Fragmentação do DNA/fisiologia , Dimiristoilfosfatidilcolina/análise , Dimiristoilfosfatidilcolina/farmacocinética , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Lipossomos/síntese química , Lipossomos/farmacocinética , Neoplasias Pulmonares/patologia , Microscopia de Fluorescência/métodos , Nanotecnologia , Polidocanol , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Tecnologia Farmacêutica/métodos , Tecnologia Farmacêutica/tendências
4.
Bioorg Med Chem Lett ; 12(22): 3251-4, 2002 Nov 18.
Artigo em Inglês | MEDLINE | ID: mdl-12392725

RESUMO

Specific accumulation and growth inhibitory effects of hybrid liposomes composed of 90 mol% dimyristoylphosphatidylcholine and 10 mol% polyoxyethylene(23)dodecyl ether were obtained in human hepatoma cells without affecting normal liver cells at all.


Assuntos
Carcinoma Hepatocelular/patologia , Lipossomos/farmacologia , Antineoplásicos/metabolismo , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Carcinoma Hepatocelular/tratamento farmacológico , Divisão Celular/efeitos dos fármacos , Dimiristoilfosfatidilcolina , Humanos , Cinética , Lipossomos/metabolismo , Polidocanol , Polietilenoglicóis , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...